Financials

News Discussions Technicals Seasonals

1228 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

CANbridge Pharmaceuticals Inc. operates as a rare disease-focused biopharmaceutical company committed to the research, development and commercialization of transformative therapies. The firm's pipeline and products include rare oncology, rare diseases, gene theraphy, Huntercase, Nerlynx, and Caphosol. It operates through the following geographical segment: Mainland China, Taiwan, and Hong Kong. The company was founded by James Xue in 2012 and is headquartered in Beijing, China.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

1228 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company